from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2255c/-

LFCtreatmentdescriptionclass of inhibitor

1.473

Amikacinug/mL Amikacintranslation

2.047

Cap5-10ug/mL Capreomycintranslation

3.672

Rox10-50 ug/mL Roxithromycintranslation

0.457

SM2-5 ug/mL Streptomycintranslation

2.794

Tet5-10 ug/mL Tetracyclinetranslation

-0.472

Rif0.2-5ug/mL Rifampicintranscription

0.226

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.104

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.377

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.119

CPZ10-50 ug/mL Chlorpromazinerespiration

0.826

Clofazimine10-13 ug/mL Clofaziminerespiration

0.118

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.476

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.128

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.044

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.236

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.773

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.235

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.467

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.468

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.050

KCN5-20 ug/mL Potassium cyaniderespiration

-0.757

NaN30.2-2 mM Sodium aziderespiration

-0.599

Nigericin50 uM Nigericinrespiration

0.490

TRC10-150 ug/mL Triclosanrespiration

1.100

TRZ10-25 ug/mL Thioridazinerespiration

3.076

Valinomycin0.5-10 uM Valinomycinrespiration

-0.141

ZnSO42 mM ZnSO4respiration

0.254

menadione6-10 ug/mL Menadionerespiration

-0.295

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.264

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.223

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.450

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.119

NRP_1Non-replicating persistence stage 1dosRassociated

-0.488

Amp0.2mg/mL AmpicillincellWall

0.320

Cephalexin20-100 ug/mL CephalexincellWall

-0.125

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.261

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.244

EMB10-20 ug/mL EthambutolcellWall

-0.015

Eta12-40 ug/mL EthionamidecellWall

0.060

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.229

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.207

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.182

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.702

BZA0.12 mg/mL BenzamidearomaticAmides

-0.742

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.559

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.285

H2O24 mM hydrogen peroxideDNAdamaging

-0.517

Levo10 ug/mL LevofloxacinDNAdamaging

-0.875

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.375

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.335

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.696

UVUV-irradiationDNAdamaging

1.034

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.613

Antimycin12.5-50 ug/mL Antimycin A?

0.129

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.595

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.437

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.165

PA8240.2-2 ug/mL PA-824?

0.352

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.212

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.021

Verapamil50 uM Verapamil?

0.133

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.092

methoxatin10-20 ug/mL Methoxatin?